|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Royalty | |||||
| Production costs | |||||
| Depreciation | |||||
| Gross profit | |||||
| Administrative expenses | |||||
| Fair value loss on derivative financial instrument | |||||
| Profit on sale of subsidiary | |||||
| Equity-settled share-based expense | |||||
| Cash-settled share-based expense | |||||
| Other expenses | |||||
| Other income | |||||
| Profit on the sale of non-current assets held for sale | |||||
| Operating profit | |||||
| Finance income | |||||
| Finance cost | |||||
| Profit before tax | |||||
| Total comprehensive income attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interests | |||||
| Other comprehensive income | |||||
| Reclassification of accumulated exchange differences on the sale of subsidiary | |||||
| Exchange differences on translation of foreign operations | |||||
| Profit (loss) attributable to: | |||||
| Owners of the Company |
Loading...
